S-1/A: Aethlon Medical Files Amendment to Registration Statement
Registration Statement Amendment
Aethlon Medical, Inc. has filed Amendment No. 2 to its Form S-1 Registration Statement, primarily to include an updated consent from its independent registered public accounting firm.
Summary
- Aethlon Medical, Inc. has filed Amendment No. 2 to its Form S-1 Registration Statement.
- This amendment is primarily to update and include the consent of the company's independent registered public accounting firm, Haskell & White LLP.
- The filing details other expenses related to the issuance and distribution of securities, including SEC registration fees, FINRA filing fees, accounting, legal, and miscellaneous expenses, totaling an estimated $450,381.52.
- It also outlines the company's indemnification of directors and officers, as permitted by Nevada Revised Statutes, and details the maintenance of directors and officers liability insurance.
- The filing references recent sales of unregistered securities, including a private placement on December 8, 2025, involving pre-funded warrants and common stock warrants, and annual restricted stock unit (RSU) awards to non-employee directors approved on March 31, 2026, and April 17, 2026.
Sentiment
Score: 3
Explanation: StockSavvy.ai views this filing as having a negative sentiment due to the explicit 'going concern' note from the auditor, despite being a procedural amendment to a registration statement.
Positives
- The company has updated its registration statement with necessary consents, indicating progress in its registration process.
- The company maintains directors and officers liability insurance, providing a layer of protection for its leadership.
- Annual RSU awards to non-employee directors demonstrate a commitment to compensating and incentivizing the board.
Negatives
- The consent from Haskell & White LLP includes an explanatory paragraph expressing substantial doubt regarding the company's ability to continue as a going concern, as of their audit for the year ended March 31, 2026.
- Significant legal and accounting fees are associated with the registration process, totaling $385,000.
Risks
- The independent registered public accounting firm has expressed substantial doubt regarding Aethlon Medical's ability to continue as a going concern.
- The company is subject to potential liabilities for which directors and officers may seek indemnification, though this is subject to legal standards and insurance coverage.
- There is no assurance that the company will maintain liability insurance for its directors and officers.
Future Outlook
The filing itself is an amendment to a registration statement and does not contain specific forward-looking financial guidance. However, the inclusion of an updated consent from the independent auditor, which notes substantial doubt about the company's ability to continue as a going concern, casts a significant shadow over any future outlook.
Industry Context
StockSavvy.ai notes that amendments to S-1 registration statements are common during the IPO or follow-on offering process. The inclusion of an auditor's 'going concern' note is a critical disclosure that often precedes significant financial restructuring or operational challenges, and investors will be closely watching how Aethlon Medical addresses this concern.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Indemnification | The company's bylaws provide for the indemnification of directors and officers to the fullest extent permitted by Nevada Revised Statutes, including mandatory payment of defense expenses. | Not specified, but governed by bylaws and NRS | Provides legal and financial protection for directors and officers against liabilities arising from their service, subject to certain conditions and legal standards. |
| Liability Insurance | The company maintains directors and officers liability insurance covering expenses and liabilities arising from certain actions. | Ongoing, subject to policy terms | Offers financial recourse for covered claims against directors and officers, mitigating personal financial risk. |
| Equity Incentive Plan | The company utilizes the Aethlon Medical, Inc. 2020 Equity Incentive Plan for granting awards such as restricted stock units. | Plan established in 2020, with amendments and grants occurring subsequently | A mechanism for incentivizing and retaining key personnel and directors through equity ownership. |
Stakeholder Impact
- Shareholders: The 'going concern' note from the auditor raises significant concerns about the company's long-term viability, potentially impacting share value and investor confidence. The potential capital raise could dilute existing shareholdings.
- Directors and Officers: The indemnification provisions and D&O insurance offer protection, but they are still subject to the company's financial health and the outcome of any potential legal proceedings.
- Employees: Uncertainty about the company's going concern status could impact employee morale and job security.
- Creditors: The 'going concern' note suggests potential difficulties in meeting financial obligations, which could affect creditors.
Next Steps
- The registration statement must be declared effective by the SEC for the proposed offering to commence.
- The company will need to address the 'going concern' issue raised by its auditors.
Key Dates
| Date | Description |
|---|---|
| 2019-09-12 | Filing of Amended and Restated Bylaws of the Company |
| 2020-10-30 | Employment Agreement between the Company and Dr. Fisher |
| 2020-11-07 | Assignment Agreement between Aethlon Medical, Inc. and London Health Sciences Center Research Inc. |
| 2020-12-07 | Lease between the Company and San Diego Inspire 1, LLC. and San Diego Inspire 2, LLC |
| 2021-01-04 | Executive Employment Agreement between the Company and Steven P. LaRosa, MD |
| 2021-01-27 | Lease between Aethlon Medical, Inc. and San Diego Inspire 5, LLC |
| 2022-02-10 | Aethlon Medical, Inc. Amended and Restated Non-Employee Director Compensation Policy, as Modified |
| 2022-03-24 | At the Market Offering Agreement between Aethlon Medical, Inc. and H.C. Wainwright & Co., LLC |
| 2023-02-01 | Executive Employment Agreement between Aethlon Medical, Inc. and Lee D. Arnold, Ph.D. |
| 2023-05-01 | Amendment No. 1 to Executive Employment Agreement between Aethlon Medical, Inc. and Lee D. Arnold, Ph.D. |
| 2023-11-07 | Amendment No. 1 to Executive Employment Agreement, between the Company and James B. Frakes |
| 2023-11-27 | Separation Agreement between the Company and Dr. Fisher |
| 2025-03-17 | Form of Inducement Letter and Form of Common Warrant to purchase Common Stock issued |
| 2025-09-04 | Form of Common Warrant and Form of Pre-Funded Warrant, dated September 4, 2025 |
| 2025-09-04 | Placement Agent Warrant, dated September 4, 2025 |
| 2025-12-05 | Placement Agency Agreement between the Company and Maxim Group LLC |
| 2025-12-05 | Form of Securities Purchase Agreement between the Company and the purchaser signatory thereto |
| 2025-12-08 | Private placement of pre-funded warrants and warrants to purchase shares of common stock |
| 2025-12-08 | Form of Warrant Inducement Agreement |
| 2026-01-22 | Amendment to Securities Purchase Agreement |
| 2026-01-22 | Amendment to Pre-Funded Common Stock Purchase Warrant |
| 2026-02-23 | Certificate of Amendment to Articles of Incorporation |
| 2026-03-31 | Board of Directors approved annual restricted stock unit (RSU) awards to non-employee directors |
| 2026-04-17 | Board of Directors approved annual restricted stock unit (RSU) awards to non-employee directors |
| 2026-06-10 | Report date of Haskell & White LLP relating to audits of consolidated financial statements |
| 2026-06-26 | Insider Trading Policy and List of Subsidiaries filed |
| 2026-06-30 | Consent of Haskell & White LLP |
| 2026-07-01 | Filing of Amendment No. 2 to Form S-1 Registration Statement |
| 2026-07-01 | Form of Placement Agency Agreement (current offering) |
| 2026-07-01 | Form of Common Warrant (current offering) |
| 2026-07-01 | Form of Pre-Funded Warrant (current offering) |
| 2026-07-01 | Form of Placement Agent Warrant (current offering) |
| 2026-07-01 | Form of Securities Purchase Agreement (current offering) |
| 2026-07-01 | Form of Lock-Up Agreement (current offering) |
| 2026-07-01 | Filing Fee Table |
Recommendation
holdThe 'going concern' note from the auditor is a significant red flag that warrants caution. While the filing is procedural for a registration statement, the auditor's doubt about the company's ability to continue as a going concern suggests substantial underlying financial risks. A 'hold' recommendation is appropriate pending further clarity on the company's financial stability and the success of any capital raise.
Keywords
Aethlon Medical, SEC Filing, Form S-1, Registration Statement, Amendment, Going Concern, Indemnification, Warrants, Restricted Stock Units, Haskell & White LLP
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.